logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hejian Zou

fudan university
H指数:38
被引数:4,216

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Firsekibart in Patients with Acute Gout Unsuitable for Standard Therapy: 48-Week Results from an Open-Label Extension of a Randomized Phase 3 Trial

Firsekibart在急性痛风患者中的疗效与安全性：一项随机III期试验开放标签扩展研究的48周结果

Advances in Therapy
IF4
2026-05-190
OA
Zaihua Zhu; Yu Xue; Tianshu Chu; Jiankang Hu; Wei Gou; Ning Zhang; Juan Li; Jing Yu; Rongping Li; Rongbin Li; Long Qian; Xinwang Duan; Lihua Duan; Qian Xu; Fei Gu; Yuling Lian; Xu Zhang; Hejian Zou
Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate-Lowering Therapy: A Phase 2, Randomized, Open-Label, Multicenter, Active-Controlled Trial

Firsekibart作为预防性治疗，用于启动降尿酸治疗患者的急性痛风发作：一项2期、随机、开放标签、多中心、活性对照试验

ACR Open Rheumatology
IF2.8
2025-11-070
OAAI
Yiyun Yu; Yu Xue; Jiankang Hu; Ning Zhang; Rongbin Li; Hongtao Guo; Long Qian; Wei Gou; Jing Yang; Li Mao; Jing Yu; Shengyun Liu; Qian Xu; Tianhong Luo; Hejian Zou
Efficacy and Safety of Firsekibart Compared to Etoricoxib for Gout Flares: A Phase 2, Multicenter, Open-label, Active-controlled, Randomized Non-inferiority Trial

Firsekibart与Etoricoxib治疗痛风发作的疗效与安全性比较：一项II期、多中心、开放标签、活性对照、随机非劣效性试验

Rheumatology and Therapy
IF2.9
2025-08-200
OAAI
Ning Kong; Yu Xue; Li Mao; Long Qian; Hongtao Guo; Jiankang Hu; Fenghong Yuan; Rongbin Li; Xinwang Duan; Jing Yu; Wei Gou; Lei Yang; Hua Wei; Rongping Li; Qian Xu; Tianhong Luo; Xu Zhang; Hejian Zou
Single-cell RNA sequencing reveals the CRTAC1+ population actively contributes to the pathogenesis of spinal ligament degeneration by SPP1+ macrophage

单细胞RNA测序揭示CRTAC1群体积极参与SPP1巨噬细胞脊柱韧带变性的发病机制

AGING CELL
IF7.1
2024-08-191
OAAI
Tang, Yulong; Zhuo, Dachun; Yu, Yuexin; Pu, Weilin; Ma, Yanyun; Zhang, Yuting; Huang, Yan; Zhang, Qing; Tang, Kunhai; Meng, Chen; Yang, Di; Bai, Lu; He, Dongyi; Jin, Li; Zou, Hejian; Xu, Huji; Zhu, Qi; Wang, Jiucun; Chen, Yuanyuan; Liu, Jing

研究方向

暂未获取到该数据
王久存 封面图
王久存
H 指数:49论文数:382被引数:9,614
X
Xiaoxia Zhu
H 指数:39论文数:167被引数:4,301
李金 封面图
李金
H 指数:149论文数:4,499被引数:12.8万
马
马彦云
H 指数:33论文数:164被引数:3,319
S
Shuai Jiang
H 指数:22论文数:89被引数:2,723
X
Xiaodong Zhou
H 指数:40论文数:100被引数:7,272
Y
Yu Xue
H 指数:28论文数:87被引数:1,885
刘庆梅 封面图
刘庆梅
H 指数:33论文数:173被引数:2,949
H
Haiyan Chu
H 指数:24论文数:61被引数:1,480
濮
濮伟霖
H 指数:24论文数:85被引数:2,027